{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:53:03Z","timestamp":1792144383687,"version":"4.4.0"},"reference-count":42,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study continues to address knowledge gaps in our understanding of type 1 diabetes and the effects of intensive therapy on its long-term complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>During the DCCT (1982\u20131993), a controlled clinical trial of 1,441 subjects with type 1 diabetes, and the EDIC (1994\u2013present), an observational study of the DCCT cohort, core data collection has included medical history questionnaires, surveillance health exams, and frequent laboratory and other evaluations for microvascular and macrovascular disease. Numerous collaborations have expanded the outcome data with more detailed investigations of cardiovascular disease, cognitive function, neuropathy, genetics, and potential biological pathways involved in the development of complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The longitudinal follow-up of the DCCT\/EDIC cohort provides the opportunity to continue monitoring the durability of intensive treatment as well as to address lingering questions in type 1 diabetes research. Future planned analyses will address the onset and progression of microvascular triopathy, evidence-based screening for retinopathy and nephropathy, effects of glycemic variability and nonglycemic risk factors on outcomes, long-term impact of intensive therapy on cognitive decline, and health economics. Three new proposed investigations include an examination of residual C-peptide secretion and its impact, prevalence of hearing impairment, and evaluation of gastrointestinal dysfunction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>With the comprehensive data collection and the remarkable participant retention over 30 years, the DCCT\/EDIC continues as an irreplaceable resource for understanding type 1 diabetes and its long-term complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc13-2148","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T23:14:52Z","timestamp":1388186092000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":107,"title":["The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Summary and Future Directions"],"prefix":"10.2337","volume":"37","author":[{"given":"Rose A.","family":"Gubitosi-Klug","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Rainbow Babies and Children\u2019s Hospital, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the DCCT\/EDIC Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,12,11]]},"reference":[{"key":"2022031222265191500_B1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031222265191500_B2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archopht.1995.01100010038019","article-title":"The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.","volume":"113","author":"The Diabetes Control and Complications Trial Research Group.","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"2022031222265191500_B3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0161-6420(95)30973-6","article-title":"Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial","volume":"102","author":"Diabetes Control and Complications Trial Research Group","year":"1995","journal-title":"Ophthalmology"},{"key":"2022031222265191500_B4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","article-title":"Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"290","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2003","journal-title":"JAMA"},{"key":"2022031222265191500_B5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N Engl J Med"},{"key":"2022031222265191500_B7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019 duration: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983\u20132005)","volume":"169","author":"Nathan","year":"2009","journal-title":"Arch Intern Med"},{"key":"2022031222265191500_B8","first-page":"3131","article-title":"The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications\/Epidemiology of Diabetes Interventions and Complications cohort","volume-title":"Diabetes Care","author":"Jacobson","year":"2013"},{"key":"2022031222265191500_B9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diab.35.5.530","article-title":"The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase","volume":"35","author":"The DCCT Research Group","year":"1986","journal-title":"Diabetes"},{"key":"2022031222265191500_B10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","author":"Epidemiology of Diabetes Interventions and Complications (EDIC)","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.111.022327","article-title":"Myocardial structure, function, and scar in patients with type 1 diabetes mellitus","volume":"124","author":"Turkbey","year":"2011","journal-title":"Circulation"},{"key":"2022031222265191500_B12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2337\/diab.46.11.1829","article-title":"Clustering of long-term complications in families with diabetes in the diabetes control and complications trial","volume":"46","author":"The Diabetes Control and Complications Trial Research Group","year":"1997","journal-title":"Diabetes"},{"key":"2022031222265191500_B13","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.2337\/db06-0653","article-title":"The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume":"55","author":"Cleary","year":"2006","journal-title":"Diabetes"},{"key":"2022031222265191500_B14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diacare.26.3.810","article-title":"Serum lipoproteins in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Intervention and Complications cohort: associations with gender and glycemia","volume":"26","author":"Jenkins","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2337\/dc07-2375","article-title":"Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"32","author":"Van Den Eeden","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes"},{"key":"2022031222265191500_B17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/diabetes.48.2.383","article-title":"Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications","volume":"48","author":"Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group","year":"1999","journal-title":"Diabetes"},{"key":"2022031222265191500_B18","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus","volume":"348","author":"Nathan","year":"2003","journal-title":"N Engl J Med"},{"key":"2022031222265191500_B19","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/diabetes.54.11.3103","article-title":"Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications participants with type 1 diabetes","volume":"54","author":"Genuth","year":"2005","journal-title":"Diabetes"},{"key":"2022031222265191500_B20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1464-5491.2009.02885.x","article-title":"The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in type 1 diabetes based on an 18-year follow-up of the DCCT cohort","volume":"27","author":"Jacobson","year":"2010","journal-title":"Diabet Med"},{"key":"2022031222265191500_B21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2337\/dc08-0607","article-title":"Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial","volume":"31","author":"Musen","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Jacobson","year":"2007","journal-title":"N Engl J Med"},{"key":"2022031222265191500_B23","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study (DCCT\/EDIC)","volume":"119","author":"Pop-Busui","year":"2009","journal-title":"Circulation"},{"key":"2022031222265191500_B24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1089\/dia.2012.0316","article-title":"Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study","volume":"15","author":"Cleary","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"2022031222265191500_B25","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.2337\/dc12-2661","article-title":"The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT\/EDIC study","volume":"36","author":"Orchard","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031222265191500_B26","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/1740774512458986","article-title":"Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus","volume":"9","author":"Kramer","year":"2012","journal-title":"Clin Trials"},{"key":"2022031222265191500_B27"},{"key":"2022031222265191500_B28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin Chem"},{"key":"2022031222265191500_B29","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.2337\/db13-0256","article-title":"Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"62","author":"Orchard","year":"2013","journal-title":"Diabetes"},{"key":"2022031222265191500_B30","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/db07-0376","article-title":"Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT\/EDIC genetics study","volume":"56","author":"Al-Kateb","year":"2007","journal-title":"Diabetes"},{"key":"2022031222265191500_B31"},{"key":"2022031222265191500_B32","author":"Aiello"},{"key":"2022031222265191500_B33"},{"key":"2022031222265191500_B34"},{"key":"2022031222265191500_B35","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/diabetes.54.4.1238","article-title":"Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT\/EDIC Genetics Study","volume":"54","author":"Boright","year":"2005","journal-title":"Diabetes"},{"key":"2022031222265191500_B36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/db07-1059","article-title":"Multiple superoxide dismutase 1\/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Genetics Study","volume":"57","author":"Al-Kateb","year":"2008","journal-title":"Diabetes"},{"key":"2022031222265191500_B37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.juro.2012.04.001","article-title":"Pilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT\/EDIC study cohort","volume":"188","author":"Hotaling","year":"2012","journal-title":"J Urol"},{"key":"2022031222265191500_B38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2337\/diabetes.48.4.870","article-title":"Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications.","volume":"48","author":"Monnier","year":"1999","journal-title":"Diabetes"},{"key":"2022031222265191500_B39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-128-7-199804010-00001","article-title":"Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial:. a randomized, controlled trial","volume":"128","author":"The Diabetes Control and Complications Trial Research Group","year":"1998","journal-title":"Ann Intern Med"},{"key":"2022031222265191500_B40","first-page":"1","article-title":"Hearing in diabetics","volume":"356","author":"Axelsson","year":"1978","journal-title":"Acta Otolaryngol Suppl"},{"key":"2022031222265191500_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-149-1-200807010-00231","article-title":"Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004","volume":"149","author":"Bainbridge","year":"2008","journal-title":"Ann Intern Med"},{"key":"2022031222265191500_B42","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/nmo.12054","article-title":"Comprehensive assessment of gastric emptying with a stable isotope breath test","volume":"25","author":"Bharucha","year":"2013","journal-title":"Neurogastroenterol Motil"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/1\/44\/618751\/44.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/1\/44\/618751\/44.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:40:52Z","timestamp":1647132052000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/37\/1\/44\/31836\/The-Diabetes-Control-and-Complications-Trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,11]]},"published-print":{"date-parts":[[2014,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc13-2148","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,11]]}}}